Literature DB >> 29657100

Synthesis of 1,2,4-triazole-linked urea/thiourea conjugates as cytotoxic and apoptosis inducing agents.

Ramya Tokala1, Swarna Bale2, Ingle Pavan Janrao1, Aluri Vennela1, Niggula Praveen Kumar1, Kishna Ram Senwar1, Chandraiah Godugu3, Nagula Shankaraiah4.   

Abstract

A new series of 1,2,4-triazole-linked urea and thiourea conjugates have been synthesized and evaluated for their in vitro cytotoxicity against selected human cancer cell lines namely, breast (MCF-7, MDA-MB-231), lung (A549) prostate (DU145) and one mouse melanoma (B16-F10) cell line and compared with reference drug. The compound 5t showed significant cytotoxicity on MCF-7 breast cancer cell line with a IC50 value of 7.22 ± 0.47 µM among all the tested compounds. Notably, induction of apoptosis by compound 5t on MCF-7 cells was evaluated using different staining techniques such as acridine orange/ethidium bromide (AO/EB), annexin V-FITC/PI, and DAPI. Further, clonogenic assay indicates the inhibition of colony formation on MCF-7 cells by compound 5t. Moreover, the flow-cytometric analysis also revealed that compound 5t caused the arrest of cells at G0/G1 phase of cell cycle. In addition, the compounds when tested on normal human cells (L-132) were found to be safer with low cytotoxicity profile.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1,2,4-Triazoles; Anticancer; Apoptosis; Flow-cytometry; Thiourea; Urea

Mesh:

Substances:

Year:  2018        PMID: 29657100     DOI: 10.1016/j.bmcl.2018.03.074

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach.

Authors:  Raja Solomon Viswas; Sheetal Pundir; Hoyun Lee
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

2.  B(C6F5)3-catalyzed dehydrogenative cyclization of N-tosylhydrazones and anilines via a Lewis adduct: a combined experimental and computational investigation.

Authors:  Murali Mohan Guru; Sriman De; Sayan Dutta; Debasis Koley; Biplab Maji
Journal:  Chem Sci       Date:  2019-07-05       Impact factor: 9.825

3.  Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation.

Authors:  Sowjanya Thatikonda; Venkatesh Pooladanda; Dilep Kumar Sigalapalli; Chandraiah Godugu
Journal:  Cell Death Dis       Date:  2020-01-10       Impact factor: 8.469

4.  Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation.

Authors:  Vinod Gangadevi; Sowjanya Thatikonda; Venkatesh Pooladanda; Geetanjali Devabattula; Chandraiah Godugu
Journal:  J Nanobiotechnology       Date:  2021-04-13       Impact factor: 10.435

Review 5.  An insight on medicinal attributes of 1,2,4-triazoles.

Authors:  Ranjana Aggarwal; Garima Sumran
Journal:  Eur J Med Chem       Date:  2020-07-27       Impact factor: 6.514

6.  Disubstituted 4-Chloro-3-nitrophenylthiourea Derivatives: Antimicrobial and Cytotoxic Studies.

Authors:  Anna Bielenica; Giuseppina Sanna; Silvia Madeddu; Gabriele Giliberti; Joanna Stefańska; Anna E Kozioł; Oleksandra Savchenko; Paulina Strzyga-Łach; Alicja Chrzanowska; Grażyna Kubiak-Tomaszewska; Marta Struga
Journal:  Molecules       Date:  2018-09-21       Impact factor: 4.411

7.  Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity.

Authors:  Ramya Tokala; Sravani Sana; Uppu Jaya Lakshmi; Prasanthi Sankarana; Dilep Kumar Sigalapalli; Nikhil Gadewal; Jyoti Kode; Nagula Shankaraiah
Journal:  Bioorg Chem       Date:  2020-10-08       Impact factor: 5.275

8.  Bostrycin inhibits growth of tongue squamous cell carcinoma cells by inducing mitochondrial apoptosis.

Authors:  Jing Jie; Le Shi; Shuohao Yue; Mo Wang; Junlin Zhang
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.